Evaluation of the Therapeutic Potential of Ipecacuanha in Potencies 12C, 30C and 200C in Penaeus Monodon Challenged with Vibrio Cholera

Authors

  • M Navena Assistant Professor, Department of Hom. Materia Medica, Jims Homoeopathic Medical College & Hospital, Hyderabad -509 325.

DOI:

https://doi.org/10.48165/ahr.2026.11.2.7

Keywords:

Bacterial load, Vibrio cholera, Penaeus monodon, Homoeopathy, Ipecacuanha, Tetracycline, Vibriosis

Abstract

Background: Vibriosis caused by Vibrio cholerae  is a major bacterial disease in shrimp aquaculture,  leading to significant economic losses. According to  reports, Vibrio cholerae is an opportunistic infection  that can cause up to 100% death and significant  output losses in shrimp farms. Lethargy, tissue and  appendage necrosis, poor development, slow larval  metamorphosis and body deformity, muscle opacity,  melanization, empty midgut, and anorexia are all  indicators of Vibrio cholerae illness. Seafood can  become contaminated by bacteria that carry the Vibrio  genes, endangering human health. Additionally,  marine items are consumed globally and have a big  impact on the economy. Seafood-borne infections  have dramatically increased globally, primarily due  to Vibrio cholerae species. The increasing concerns  over antibiotic resistance necessitate the exploration  of alternative Homeopathic therapeutic approaches.  Objective: The present study aimed to evaluate the  efficacy of the homeopathic medicine Ipecacuanha at  potencies 12C, 30C, and 200C in Penaeus monodon  experimentally infected with Vibrio cholerae. Methods: A total of 200 shrimps were divided into five  groups. Vibrio cholerae infection was experimentally  induced in shrimp Penaeus monodon, which were  divided into five groups (n = 40 per group). Group A  served as the untreated control, while Group B was  administered tetracycline (10 mg kg⁻¹). Groups C, D  and E were treated with the homeopathic medicine  Ipecacuanha at potencies of 12C, 30C and 200C  respectively. The study was conducted over a 30-day  period, during which bacterial load was assessed on  days 10, 20 and 30 post-infections. Concurrently,  growth parameters (length and weight), cumulative  mortality index (CMI) and survival rates were  recorded and analyzed.  Results: Results demonstrated a reduction in bacterial  load and improvement in growth performance, CMI  and survival rate in all Ipecacuanha treated groups  compared to the control. Among the tested potencies,  30C exhibited the most pronounced effect of Reduced  mortality, increased survival rate, weight gain and  lower bacterial load. Statistical analysis indicated  that the observed findings were significant, with a  P-value of < 0.05. Conclusion: The findings indicate that Ipecacuanha  30C potency has an effective therapeutic action for  treating Vibrio cholerae infection in shrimp Penaeus  monodon. The test is significant since the cumulative mortality in the 30-day timeframe of the experimental  trial has a P value of less than 0.05. This study  determines the potential application of homeopathic  medicines in sustainable aquaculture practices and  highlights the need for further investigations to  validate these results.

 

References

Soumya Haldar SC. Vibrio related diseases in aquaculture and development of rapid and accurate identification methods. J Mar Sci Res Dev. 2012;S1(1):1–7.

Kriem MR, Banni B, El Bouchtaoui H, Hamama A, El Marrakchi A, Chaouqy N, et al. Prevalence of Vibrio spp. in raw shrimps (Parapenaeus longirostris) and performance of a chromogenic medium for the isolation of Vibrio strains. Lett Appl Microbiol. 2015;61(3):224–230.

Nahar S, Sultana M, Naser MN, Nair GB, Watanabe H, Ohnishi M, et al. Role of shrimp chitin in the ecology of toxigenic Vibrio cholerae and cholera transmission. Front Microbiol. 2012;2:1–8.

Bonnin-Jusserand M, Copin S, Le Bris C, Brauge T, Gay M, Brisabois A, et al. Vibrio species involved in seafood-borne outbreaks (Vibrio cholerae, V. parahaemolyticus and V. vulnificus): Review of microbiological versus recent molecular detection methods in seafood products. Crit Rev Food Sci Nutr. 2019;59:597–610.

Faruque SM, Albert MJ, Mekalanos JJ. Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev. 1998;62:1301–1314.

Dobell C, Laidlaw PP. The action of ipecacuanha alkaloids on Entamoeba histolytica and some other entozoic amoebae in culture. Parasitology. 1926;18(2):206–223.

Moriarty DJW. Disease control in shrimp aquaculture with probiotic bacteria. Atlantic Canada Society for Microbial Ecology; 1999.

Koralage MSG, Alter T, Pichpol D, Strauch E, Zessin KH, Huehn S. Prevalence and molecular characteristics of Vibrio spp. isolated from preharvest shrimp of the North Western Province of Sri Lanka. J Food Prot. 2012;75(10):1846–1850.

Naveen PK. Veterinary Homoeopathy. Thrissur District, Kerala, India: Pushpa Naveen Publisher; 2016.

Rajendran ES. Nanodynamics. Kerala, India: Mohna Publications; 2015.

Luo PG, Yang F, Yang ST, Sonkar SK, Yang L, Broglie JJU, et al. Carbon-based quantum dots for fluorescence imaging of cells and tissues. RSC Adv. 2014;4:10791–10807.

Sarkar BK. Hahnemann's Organon of Medicine. 5th ed. Delhi: Birla Publications; 2004.

Morris JG. Cholera and other types of vibriosis: A story of human pandemics and oysters on the half shell. Clin Infect Dis. 2003;37(2):272–280.

Lekshmy S, Nansimole A, et al. Occurrence of Vibrio cholerae in shrimp culture environments of Kerala, India. Indian J Sci Res. 2014;5(2):27–31.

Shanmugasundaram S, Mayavu P, Manikandarajan T, Suriya M, Eswar A, Anbarasu R. Isolation and identification of Vibrio sp. in the hepatopancreas of cultured white Pacific shrimp (Litopenaeus vannamei). Int Lett Nat Sci. 2015;46:52–58.

Mohamed T, Balakrishnan IS, Ansari ST, Osman M. Editors-in-Chief. Int J Sci Humanit. 2014;4.

Kumar VS. Shrimp exports to South Africa may take a hit over presence of Vibrio cholera bacteria. 2017.

Bonnin-Jusserand M, Copin S, Le Bris C, Brauge T, Gay M, Brisabois A, et al. Vibrio species involved in seafood-borne outbreaks (Vibrio cholerae, V. parahaemolyticus and V. vulnificus): Review of microbiological versus recent molecular detection methods in seafood products. Crit Rev Food Sci Nutr. 2019;59:597–610.

Tang KFJ. Impacts of acute hepatopancreatic necrosis disease on commercial shrimp aquaculture. Rev Sci Tech. 2019;38(2):477–490.

Boonyawiwat V, Patanasatienkul T, Kasornchandra J, Poolkhet C, Yaemkasem S, Hammell L, et al. Impact of farm management on expression of early mortality syndrome/acute hepatopancreatic necrosis disease (EMS/AHPND) on penaeid shrimp farms in Thailand. J Fish Dis. 2017;40(5):649–659.

Santiago TC. Diagnosis and Management of Shrimp Diseases. Chennai: Central Institute of Brackishwater Aquaculture; 2005. p. 9.

Santiago TC. Diagnosis and Management of Shrimp Diseases. Chennai: Central Institute of Brackishwater Aquaculture; 2005. p. 12.

Santiago TC. Diagnosis and Management of Shrimp Diseases. Chennai: Central Institute of Brackishwater Aquaculture; 2005. p. 28.

Santiago TC. Diagnosis and Management of Shrimp Diseases. Chennai: Central Institute of Brackishwater Aquaculture; 2005. p. 29.

Allen TF. The Encyclopedia of Pure Materia Medica. Vol. 10. New York: Boericke & Tafel.

Mondal TC. Textbook of Homoeopathic Materia Medica. Vol. 1. Kolkata: Books and Allied (P) Ltd.; 2000.

Murphy R. Lotus Materia Medica. 2nd rev. ed. New Delhi: B. Jain Publishers; 2000.

Hering C. Hering's Guiding Symptoms of Our Materia Medica. Vol. 3. New Delhi: B. Jain Publishers; 2003.

Boericke W. Materia Medica. Available from: MateriaMedica.info.

Bacterial Disease of Shrimp. Biol Prod. 2017. Available from: Vinnbio.

Published

2026-06-10

How to Cite

Evaluation of the Therapeutic Potential of Ipecacuanha in Potencies 12C, 30C and 200C in Penaeus Monodon Challenged with Vibrio Cholera. (2026). Advancements in Homeopathic Research, 11(2), 49-57. https://doi.org/10.48165/ahr.2026.11.2.7